Key words biopsy - abdomen - thorax - interventional procedures
Introduction
Since the pioneering study of Haaga and Alfidi [1 ], who initially described computed tomography (CT) as an interventional guidance
tool in 1976, CT has become an accepted and effective method for assisting percutaneous
biopsies [2 ]
[3 ]
[4 ]
[5 ]
[6 ].
CT offers high spatial resolution, good image contrast, a wide field of view, good
reproducibility and applicability to bony and air-filled structures. Conventional
CT with an intermittent control mode as well as fluoroscopic CT with a real-time mode
play an important role especially in thoracic and abdomino-pelvic biopsy approaches
which cannot be adequately guided by fluoroscopy or ultrasonography [7 ]
[8 ]
[9 ]
[10 ]
[11 ]
[12 ]
[13 ]
[14 ].
With the development of C-arm fluoroscopic cone-beam computed tomography (CACT), an
additional guidance tool in the interventional armamentarium has become available
with increasing acceptance in radiology [15 ]
[16 ]
[17 ]. In general, CACT provides the capability to generate CT-like cross-sectional images
using a state-of-the-art flat-panel detector C-arm angiographic system [15 ]. However, C-arm cone-beam CT images provide restricted image quality in terms of
contrast resolution [15 ]
[16 ]
[17 ]
[18 ]
[19 ]. An approach to improve the accuracy of tumor targeting despite lower image quality
may be the coupling of C-arm cone-beam CT with an electromagnetic navigation system
in the guidance of biopsies [20 ].
To date, only a few studies addressing the role of C-arm cone-beam CT-based electromagnetic
tracking (EMT) of percutaneous biopsies have been published, and this guiding technique
seems to be relatively new to the field of interventional radiology [17 ]
[20 ]. Preliminary work describing the clinical efficacy of cone-beam CT coupled with
electromagnetic navigation in biopsy procedures has been reported [20 ]. The outcome of these procedures has been reported in a small case series of patients
with target lesions not sensitive for respiratory motion.
Consequently, the purpose of this study was to evaluate cone-beam CT-based electromagnetic
navigation of biopsy procedures in a larger series of patients with special focus
on target lesions in greater part potentially influenced by respiratory misregistration.
Materials and Methods
Study Sample
53 patients (22 women, 31 men; mean age, 62 years ± 15; age range, 26 – 83 years)
were referred to cone-beam CT-based electromagnetic navigation of biopsy procedures.
All patients had an indication for percutaneous CT-guided needle biopsy which had
been approved by an interventional radiologist. All patients had received contrast-enhanced
CT imaging prior to the intervention. All interventions were performed by two board-certified
interventional radiologists. Patients were selected on an intent-to-treat basis defined
just before initiation of the biopsy approach. Exclusion criteria were pulmonary nodules
smaller than 10 mm in greatest diameter, ascites, pacemaker patients, thrombocytopenia,
elevated prothrombin time (> 13.5 s), or increased international normalized ratio
(> 1.3). All patients were examined and treated as part of routine care and gave informed
consent prior to the intervention. The local institutional review board waived its
approval.
CACT/EMT -Guided Biopsy Procedures
All biopsy procedures were carried out in the angiography suite equipped with a state-of-the-art
flat-panel detector C-arm angiographic system (Axiom Artis, Siemens AG, Healthcare
Sector, Forchheim, Germany) including dedicated software for the acquisition of cross-sectional
cone-beam CT-like images (DynaCT, Siemens AG, Healthcare Sector, Forchheim, Germany).
The C-arm angiographic system was coupled with a sophisticated EMT system (iGuide
CAPPA, CAS innovations GmbH, Erlangen, Germany). Biopsy mode for cone-beam CT parameters
were: tube potential 90 kVp, body-weight adapted tube current setting ranging from
160 to 465 mA, standardized system dose 0.36 µGy per pulse, C-arm rotation time 8 s,
total projection angle 240°, and 0.5° projection increment. CACT raw data were acquired
without zoom, 480 mm field of view, 185 mm cylindrical volume coverage in craniocaudal
orientation, 225 mm sagittal and transverse orientation. Using 2 × 2 binning, the
in-plane spatial resolution was 0.46 mm². After raw data acquisition, data were transferred
to a dedicated workstation (syngo Workplace, Siemens AG, Healthcare Sector, Forchheim,
Germany) for multiplanar reformats with an isovolumetric voxel size of 0.4 mm³. The
slice thickness of those multiplanar reformats ranged between 10 and 20 mm.
CACT/EMT-guided thoracic or abdominal biopsy procedures were conducted as follows:
Patients were positioned in a prone or supine position to ensure the most direct access.
Prior to the procedure an oval reference frame and an additional motion sensor both
connected with the EMT system were fixed in close proximity to the region of interest
on the skin of the patients. Five radiopaque markers and an electromagnetic sensor
with weak current were integrated within the reference frame.
Short-time fluoroscopy was used to ensure that the area of interest was placed in
the isocenter and the reference frame within the area of interest. All procedures
started with a CACT acquisition of the region of interest. During CACT acquisition
contrast media was not used, since all patients had undergone prior contrast-enhanced
CT for correlation imaging in terms of lesion detection. Thereafter, the C-arm was
moved away from the patient and an electromagnetic field generator (Aurora, Northern
Digital, Waterloo, ON, Canada), connected to the EMT system, was pivoted to the area
of interest. As a next step the length of the needle path (distance between skin surface
and center of the lesion) was measured on the cathode-ray tube monitor of the imager.
CACT images were transferred to the EMT system providing a resolution of 1280 × 1024
pixels. Due to the spatial relation of the electromagnetic sensor to the radiopaque
markers within the reference frame, an automatic allocation of imaging space and electromagnetic
space was conducted.
All biopsy procedures were performed under sterile conditions. Local anesthesia consisted
of subcutaneous injection of 1 % mepivacaine. A coil-integrated coaxial tracking needle
(11- to 18-gauge, needle length between 50 and 150 mm; Amedo, Bochum, Germany) with
an introducer stylet was steered into the electromagnetic space. The size of the selected
coaxial tracking needle strongly depended on the aimed target tissue and the restricted
assortment provided by the manufacturer. The current induced into the tracking needle
coil was usually low and depended on its location and direction. By gentle manipulation
of the tracking needle, electromagnetic data and CACT imaging data were merged to
a real-time image displaying the anatomic region of interest as well as a virtual
needle on the monitor ([Fig. 1 ]). Thus, precise needle insertion into the target lesion was possible. The initial
puncture was conducted without penetrating the pleura or peritoneum. If the coil-integrated
coaxial tracking needle had not been maneuvered within the correct course, the needle
track or puncture site was changed. Each approach was considered to be successful
whenever the needle had been accurately visualized within the target lesion ([Fig. 2 ], [3 ], [4 ], [5 ]). We usually aimed for the periphery of a lesion in order to avoid necrosis. The
needle end position was verified by the virtual fusion image alone. In general, CACT
acquisitions for thoracic and upper abdominal biopsy procedures were obtained in end-inspiration
technique. This technique was used to avoid inadvertent puncture of critical anatomical
or non-target structures with better patient compliance in comparison to end-exspiration
breath holding.
Fig. 1 Situation during a CACT/EMT-guided biopsy maneuver after CACT acquisition. Left image:
Under sterile conditions the coaxial tracking needle is steered within the electromagnetic
space and a merged CACT/EMT image is displayed on a separate monitor so that accurate
needle insertion into the target lesion is possible. Right image: Note manipulation
of the tracking needle in close proximity to the fixed field generator creating the
electromagnetic space.
Abb. 1 Situation während einer FD-CT-/EMN-gesteuerten Biopsie nach FD-CT-Akquisition. Linkes
Bild: Unter sterilen Bedingungen wird die koaxiale Führungsnadel innerhalb des elektromagnetischen
Wechselfeldes gesteuert, und ein fusioniertes FD-CT-/EMN-Bild wird auf einem separatem
Monitor wiedergegeben, sodass eine präzise Nadelinsertion in die Zielläsion möglich
ist. Rechtes Bild: Die Manipulation der Führungsnadel in unmittelbarer Nähe zum fest
installierten Feldgenerator erzeugt das elektromagnetische Wechselfeld.
Fig. 2 CACT/EMT-assisted biopsy of a subpleural pulmonary nodule in segment 8 of the right
lobe. a Preprocedural diagnostic axial MSCT scan of a 71-year-old man in prone position clearly
depicts the pulmonary lesion. b CACT/EMT-guided biopsy images in axial and coronal projection demonstrate accurate
advancement of the virtual coaxial tracking needle toward the lesion. Correct needle
position is verified by the fusion image alone, although the situation is very sensitive
to respiratory motion. Histopathological examination yielded non-small cell lung cancer.
Abb. 2 FD-CT-/EMN-gestützte Biopsie eines subpleuralen Lungenrundherdes im Segment 8 des
rechten Lappens. a Die präprozedurale diagnostische axiale MSCT-Aufnahme eines 71 Jahre alten Mannes
in Bauchlage zeigt deutlich die pulmonale Läsion. b Die FD-CT-/EMN-gesteuerten Biopsiebilder in axialer und koronarer Projektion demonstrieren
eine präzise Positionierung der virtuellen koaxialen Führungsnadel innerhalb der Läsion.
Die korrekte Nadelposition wird anhand des alleinigen Fusionsbildes verifiziert, obwohl
die Position als sehr anfällig in Bezug auf Atembewegungen gilt. Die histopathologische
Untersuchung erbrachte ein nicht-kleinzelliges Bronchialkarzinom.
Fig. 3 CACT/EMT-guided biopsy of a lymph node within the retrocrural space. a Preinterventional axial MSCT scan obtained in a 74-year-old woman in a prone position
shows multiple lymph nodes within the retrocrural space. b During CACT/EMT-assisted biopsy that is displayed in axial and sagittal projection,
the virtual coaxial tracking needle is correctly inserted into a left-sided lymph
node. The diagnosis was recurrent lymphoma.
Abb. 3 FD-CT-/EMN-gesteuerte Biopsie eines Lymphknotens innerhalb des Retrokruralraums.
a Die präinterventionelle axiale MSCT-Aufnahme einer 74 Jahre alten Frau in Bauchlage
zeigt multiple Lymphknoten innerhalb des Retrokruralraums. b Während der FD-CT-/EMN-gestützten Biopsie in axialer und sagittaler Projektion wird
die virtuelle koaxiale Führungsnadel korrekt in einen linksseitigen Lymphknoten geführt.
Die Diagnose ergab ein Rezidiv eines Lymphoms.
Fig. 4 CACT/EMT-guided biopsy of a mass in the head of the pancreas. a Preinterventional axial MSCT scan of a 74-year-old man in a prone position demonstrates
the mass within the pancreatic head. b CACT/EMT images in axial and sagittal projection show the virtual needle with its
tip within the mass that established the diagnosis of adenocarcinoma.
Abb. 4 FD-CT-/EMN-gesteuerte Biopsie einer Massenläsion im Pankreaskopf. a Die präinterventionelle axiale MSCT-Aufnahme eines 74 Jahre alten Mannes in Bauchlage
zeigt die Massenläsion innerhalb des Pankreaskopfes. b Die FD-CT-/EMN-Bilder in axialer und sagittaler Projektion zeigen die virtuelle Nadel
mit ihrer Spitze innerhalb der Massenläsion, bezüglich der die Diagnose eines Adenokarzinoms
gestellt wurde.
Fig. 5 CACT/EMT-navigated biopsy of periportal lymphatic tissue 7 months after total pancreatectomy
due to carcinoma. a Preprocedural diagnostic MSCT of a 58-year-old woman in a supine position reveals
circumscribed periportal tissue. b During CACT/EMT-guided biopsy that is illustrated in axial and sagittal projection,
the coaxial tracking needle is carefully navigated toward the tissue margin. Histopathological
examination did not yield malignancy.
Abb. 5 FD-CT-/EMN-navigierte Biopsie periportalen lymphatischen Gewebes 7 Monate nach totaler
Pankreasresektion wegen eines Karzinoms. a Die präprozedurale diagnostische axiale MSCT-Aufnahme einer 58 Jahre alten Frau zeigt
das umschriebene periportale Gewebe. b Während der FD-CT-/EMN-gesteuerten Biopsie in axialer und sagittaler Projektion wird
die koaxiale Führungsnadel vorsichtig in Richtung Randbereich des Gewebes navigiert.
Die histopathologische Untersuchung erbrachte keine Malignität.
All tissue biopsies were completed with a detachable, 16- or 20-gauge cutting needle
biopsy system (Angiotech, Gainesville, FL, USA) consisting of an outer coaxial cutting
needle around a central notched stylet (length of the specimen notches measuring 10
or 20 mm). The needle length ranged from 100 to 200 mm. The central notched detachable
stylet allowed withdrawal of a core biopsy specimen while leaving the cutting needle
in place. After removal of the introducer stylet from the coaxial tracking needle,
the cutting needle was positioned and the biopsy system was released. No on-site cytopathologist
was present during the procedures. The tissue core biopsies were defined as being
suitable for histopathological examination if a solid cylinder with a length of at
least 6 to 10 mm was obtained. The tissue core biopsies were fixed in a formalin solution
for histopathological examination.
CACT/EMT-guided biopsies were defined as successful if representative tissue for a
definitive histopathological diagnosis was obtained and agreed with the final diagnosis.
Referring to this, all malignant diagnoses were categorized as representative. Benign
diagnoses were classified as representative if a benign neoplasm or specific infection
was diagnosed and as non-representative if the biopsy sample yielded nonspecific benign
changes (e. g. inflammation, inflammatory epiphenomena, or fragments of fibrosis).
Non-diagnostic specimens (e. g. samples showing scanty tissue, skeletal muscle cells,
or blood) were also considered as non-representative. All non-representative tissue
samples were verified by repeated CT-guided percutaneous biopsy procedures, surgical
biopsy or 6 to 12-week follow-up CT examinations.
After each thoracic biopsy procedure, single-shot C-arm fluoroscopic controls were
performed to evaluate the presence of complications. After abdominal CACT/EMT-guided
biopsies, ultrasound controls were conducted on-site. An additional MSCT examination
was only initiated in cases of inconclusive fluoroscopy or ultrasound studies.
Primary endpoints of the study were the number of representative biopsy samples and
the rate of complications. In addition, the mean diameter of the target lesions, the
mean needle path length, the mean number of core biopsy specimens, the mean number
of individual CACT acquisitions, the mean total procedure time (from starting CACT
until obtaining a suitable biopsy sample), the mean fluoroscopy time, and the mean
effective dose were evaluated.
Complications of treatment were classified on the basis of outcome according to the
quality improvement guidelines for percutaneous needle biopsy of the Society of Interventional
Radiology [21 ]. Minor complications included those resulting in no therapy and no consequence (class
A) or minimal therapy and no consequence including overnight admission for observation
only (class B). Major complications included those that required therapy or minor
hospitalization for less than 48 hours (class C); those that required major therapy,
unplanned increase in level of care, or prolonged hospitalization for more than 48
hours (class D); those that resulted in permanent adverse sequelae (class E); and
those that resulted in death (class F).
Statistical Analysis
Descriptive data are presented as arithmetic means with standard deviation and range,
if appropriate; categorical data are given as counts and percentages. Statistical
analysis was performed with a specialized computed algorithm (MedCalcSoftware, version
6, Mariakerke, Belgium).
Results
19 thoracic and 34 abdominal biopsy procedures were performed in 53 patients (22 women,
31 men) with cone-beam CT-based electromagnetic navigation. Details pertaining to
the location of the lesions and kind of target tissue biopsied are presented in the
[Table 1 ].
Table 1
Location of lesions and kind of target tissue biopsied using cone-beam CT-based electromagnetic
navigation.
Tab. 1 Lokalisation der Läsionen und Art des Zielgewebes, die unter Flachdetektor-CT-basierter
elektromagnetischer Navigation biopsiert wurden.
characteristic
no.
location of lesions
thorax
supraclavicular/cervical
3
pulmonary
9
mediastinal
5
pleural
1
paravertebral
1
abdomen
intraperitoneal
16
retroperitoneal
7
pelvic
9
vertebral
2
target tissue
lung tissue
9
hepatic tissue
14
lymphatic tissue
17
soft tissue
8
osseous tissue
3
pancreatic tissue
1
nerval tissue
1
The mean (± SD) number of core biopsy specimens obtained in each patient was 3.9 ± 1.3
(range, 1 – 8 core biopsy specimens). The mean (± SD) diameter of the target lesion
was 45 ± 23 mm (range, 12 – 97 mm). The mean needle path length (± SD) (distance between
the skin surface and the center of the target lesion) was 69 ± 31 mm (range, 19 – 140 mm).
The mean (± SD) number of individual CACT acquisitions was 1.4 ± 0.7 (range, 1 – 4
acquisitions). The mean total procedure time (± SD) was 9 ± 5 minutes (range, 3 – 23
minutes). The mean (± SD) fluoroscopy time was 0.8 ± 0.4 minutes and ranged between
0.4 and 2 minutes. The mean dose-area product was 7373 ± 5075 cGy cm² with a range
between 895 and 26 904 cGy cm². Applying the mean dose-area product and an effective
dose conversion factor of 0.0012 mSv × Gy–1 × cm–2 given by the manufacturer, an estimated mean effective dose of 7 mSv was calculated
for CACT acquisitions.
Of 53 CACT/EMT-guided biopsy procedures, 40 (75 %) lesions were malignant and 13 (25 %)
lesions were benign. A representative benign histopathological diagnosis was obtained
in 13 biopsy procedures and a representative malignant histopathological diagnosis
was obtained in 35 biopsy procedures, which was consistent with a technical success
rate of 91 %. 5 of 53 (9 %) histopathological tissue samples were non-representative,
2 of them were non-diagnostic and 3 of them were nonspecific. In four patients with
a non-representative CACT/EMT-guided biopsy sample, definitive malignant diagnoses
were confirmed by surgical biopsy. In one further patient with a non-representative
specimen, CT-guided biopsy was performed and yielded malignancy. The locations of
the non-representative results were the liver (metastatic liver disease in two patients,
hepatocellular carcinoma in one patient), the lung (non-small cell lung cancer in
one patient), and the supraclavicular fossa (lymphoma in one patient).
The overall rate of complications following the coupling of CACT- and EMT-guided biopsies
was 6 %. Minor complications categorized as class B occurred in two patients who suffered
from self-limiting hemoptysis. A further minor class B complication was observed in
one patient who developed a pneumothorax that did not require tube drainage. Major
complications such as life-threatening hemorrhage or unintentional puncture of critical
anatomical structures did not occur.
Discussion
The usefulness of CT-guided percutaneous thoracic and abdominopelvic biopsy has been
extensively studied [1 ]
[4 ]
[7 ]
[12 ]
[13 ]
[14 ]. Definitely, CT has been proven to be an effective guidance technique for obtaining
diagnostic specimens especially in anatomical regions which are considered inaccessible
when utilizing alternative guidance modalities such as conventional fluoroscopy or
ultrasonography [7 ]
[13 ]
[14 ]. Some investigators who examined the usefulness of CT coupled with magnetic guidance
inferred that this combination might be beneficial in terms of accuracy and safety,
especially in out-of-plane biopsy approaches [22 ].
In a most recent phantom study, Appelbaum et al. [23 ] evaluated the combination of CT and EMT in biopsy guidance of small lesions. The
authors concluded that CT/EMT guidance led to high accuracy with regard to needle
placement, thus reducing time and potentially radiation exposure in comparison with
conventional CT alone. CACT/EMT guidance is a relatively new innovative technique
[20 ]
[23 ]. Compared with data obtained with exclusive CT or CACT guidance in the literature
[7 ]
[12 ]
[14 ]
[24 ]
[25 ]
[26 ], our results showed comparable diagnostic yield values for CACT/EMT-guided biopsy
procedures. In our opinion, the reason is twofold: First, despite a slight degradation
in image quality electromagnetic navigation per se ensured good control of the virtual
needle tip during the procedure in real-time. Due to simultaneous monitoring in a
second plane, angling of the needle to avoid transgressing anatomical structures did
not represent a major problem, and the correct course of the needle toward the target
could be immediately imaged. Second, the phenomenon of respiratory misregistration
could be minimized by creation of a monitored warning signal (red bar instead of green
bar), as long as breath-hold levels had been subject to great variations. Nevertheless,
verification of needle positioning by virtual fusion image alone, especially in regions
very sensitive for varying tumor position due to different respiratory motion cycles,
as performed in our study, might be problematic. In this context, it may be hypothesized
that visualization of the needle end position by an additional CACT acquisition might
have increased the number of representative specimens. However, it should be mentioned
that exclusive CACT-guided biopsies without EMT in special anatomic regions may result
in high success rates that leave little room for improvement [19 ]
[24 ]
[25 ]
[26 ].
The purpose of our study was to evaluate cone-beam CT-based electromagnetic navigation
of biopsy procedures in a larger series of patients with a special focus on target
lesions in greater part influenced by respiratory misregistration. These lesions were
predominantly located in the thoracic cavity, liver, or pancreas, and therefore might
have been affected by respiration. Aside from the well-known problem of respiratory
motion in the thoracic cavity, there is clear evidence that intraperitoneal organs
such as the liver and the spleen move considerably with respiration because of their
close proximity to the diaphragm [27 ]. As a consequence, accurate placement of biopsy needles may be impeded. Motion of
intraperitoneal organs with respiration is generally regarded to be a complex feature
that combines cranio-caudal, lateral, and anterior-posterior movements as well as
movement due to tissue elasticity [27 ]
[28 ]. It has also been documented that the pancreas, although located in the retroperitoneal
space, may be affected by respiratory excursions [28 ].
One may criticize that our cohort study does not provide accuracy data. A control
C-arm CT image with the needle in place could have been fused with the planning CT
to calculate all relevant targeting errors such as total error, lateral error, longitudinal
error, and angular error. However, a recent study has already addressed this topic
and revealed accurate needle location in phantoms as well as in patients [20 ]. For that reason our study focused on the technical success of lesion targeting.
An interesting alternative approach has been studied by Schullian et al. [29 ] who evaluated CT-guided stereotactic liver biopsy by coupling an optical-based navigation
system and a stereotactic aiming device. The authors reported high targeting accuracy
data in terms of lateral and angular errors, and a diagnostic yield of 97.8 % that
was even slightly higher than that in our cohort study. Most recently, promising targeting
accuracy results with the use of a modified guidance technique, consisting of CACT
and stereotactic navigation, have also been found for the puncture of a liver lesion
in a phantom study [30 ]. A subsequent trial further compared CACT-guided versus multislice CT (MSCT)-guided
stereotaxy in the puncture of liver lesions. In this phantom study, the investigators
concluded that CACT enabled stereotactic targeting accuracy similar to that of MSCT.
However, those phantom studies were limited by missing respiratory motion and patient
movement that would be found in a clinical setting [30 ]
[31 ].
Concerning the non-representative samples in our study, it might be speculated that
contrast-enhanced CACT acquisitions might have increased the diagnostic yield in those
three patients with malignant liver disease. In our opinion, respiratory motion was
the reason for a further non-representative sample in a patient with non-small cell
lung cancer in his left lower lobe. The reason for another non-representative sample
in a patient with supraclavicular lymphoma remains unclear.
In the present study, the estimated mean effective patient dose for CACT/EMT-guided
biopsy procedures was lower than the dose for CT-guided biopsies. This finding was
in accordance with data reported in clinical literature [10 ]
[19 ], although we would have expected much lower values for CACT. We believe that these
results are caused by the higher number of CACT acquisitions in some patients. In
those patients the region of interest had not been captured by the first CACT acquisition,
mainly due to the limited field of view.
Since CACT acquisitions have to be performed with the radiologist inside the angiography
suite [15 ]
[17 ]
[20 ], consequent radioprotection with aprons, thyroid shields, eyeglasses, ceiling-mounted
lead shields, and mobile lead barriers is of utmost importance. If there is separated
space within the angio suite with open view protected by lead glass, there will be
no radiation exposure during CACT acquisition.
There are multiple advantages of cone-beam CT-based electromagnetic navigation of
biopsy procedures. In many institutions CT units must have a high throughput of patients.
Availability of those units for CT-guided interventions may be limited. As a consequence,
performance of biopsy procedures in the angiography suite may improve the availability
of CT units for the daily routine. Usually, there are better sterile conditions in
an angiography suite. In addition, patient comfort was felt to be higher during cone-beam
CT-based electromagnetic navigation with the interventional radiologists standing
next to the patient during the whole biopsy procedure. Moreover, patients were not
placed within the CT gantry that may lead to claustrophobia. Another benefit of an
EMT system may be the possibility of planning of the biopsy path prior to the procedure.
This may lead to better histopathological outcomes with fewer complications.
One disadvantage of cone-beam CT-based electromagnetic navigation of biopsy procedures
is its cost. In this context, the purchase price for the EMT system is about 100 000 €
and the cost of each deployed coaxial tracking needle is about 120 €. Nevertheless,
cost has to be considered in relative terms, since transfer of biopsy procedures from
the CT unit to the angiography suite may result in an increase of routine CT examinations
and a higher throughput of patients. However, this hypothesis needs to be proven in
a cost-benefit analysis. Aside from this aspect, the problem of expensive coil-integrated coaxial needles may
be generally overcome by using a stereotactic aiming device [29 ]
[30 ]
[31 ]. Another important factor is that CACT-based electromagnetic navigation procedures
may be associated with a learning curve concerning patient positioning, positioning
of the reference frame, individual CACT acquisition, and biopsy performance. As expressed
by the range of CACT acquisitions in our study, scanning may be very demanding, since
the field of view is generally restricted [15 ]
[16 ]
[17 ]
[19 ]
[20 ]
[21 ]
[22 ]
[23 ]
[24 ]
[25 ]
[26 ].
The wide range of core biopsy specimen numbers in our study has to be attributed to
the fact that in some cases fragmentation of biopsy specimens was observed. Generally,
fragmented biopsy specimens may have an impact on adequate histopathological examination
[32 ].
The complications (pneumothorax, hemoptysis) that occurred in our study are common
in the context of lung biopsies. They relate to the lung and have to be designated
as organ-specific. In comparison, generic complications refer to those that are common
to all biopsies [21 ].
There are three main limitations of our study. First, our study is limited by the
small sample size of 53 consecutive patients, preventing us from generalizing the
results. As a consequence, we consider the results of our study preliminary. Second,
the study was retrospective and lacked randomization. A prospective randomized trial
would be beneficial for defining the exact value of CACT/EMT-guided biopsies compared
with MSCT guidance. However, the major drawback of this study is the heterogeneity
of target location resulting in difficulty generalizing the technical advantage of
this combined approach regarding potential benefits such as time, dose reduction,
and the accuracy of targeted biopsy.
CACT combined with EMT appears to be an effective technique for the guidance of percutaneous
biopsies with a low rate of therapeutically relevant complications. However, this
technique requires further prospective randomized evaluation with larger patient populations
to fully assess its potential in comparison with MSCT guidance.
Clinical Relevance of the Study
The combination of CACT and EMT presents a feasibleand innovative technique in the
guidance of percutaneous biopsies.
CACT/EMT-guided percutaneous biopsy approaches are associated with a good technical
success rate of lesion targeting.
CACT coupled with EMT seems to be a relatively safe guidance technique for percutaneous
biopsies.